2019-nCoV Nucleocapsid protein (N-His) (STJP000025)

SPECIFICATIONS
HostE.coli
ConjugationUnconjugated
ImmunogenRecombinant SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Ala419) of SARS-COV-2 (2019-nCoV) Nucleocapsid (Accession #QHD43423.2) fused with an 6×His tag at th
STJP000025-100
🚚 Free UK Delivery on orders over £150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short Description2019-nCoV Nucleocapsid-N-His protein was developed in e.coli using the region Met1-Ala419. For use in research applications.
HostE.coli
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

ConjugationUnconjugated
FormulationSupplied as a 0.22 Mu m filtered solution in 20mM Tris, 500mM NaCl, 0.1mM EDTA, 10% Glycerol, pH 8.0.
Storage InstructionStore at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Immunoreactivity1.Measured by its binding ability in a functional ELISA. Immobilized Recombinant SARS-CoV-2 Nucleocapsid at 2 Mu g/mL (100 Mu L/well) can bind Anti-Nucleocapsid antibody with a linear range of 0.12-1.64 ng/mL.|2.Measured by its binding ability in a f
Determination Method< 1.0 EU/Mu g of the protein by LAL method.

Target Information

ImmunogenRecombinant SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Ala419) of SARS-COV-2 (2019-nCoV) Nucleocapsid (Accession #QHD43423.2) fused with an 6×His tag at th
Immunogen RegionMet1-Ala419
Immunogen SequenceMSDNGPQNQRNAPRITFGGP SDSTGSNQNGERSGARSKQR RPQGLPNNTASWFTALTQHG KEDLKFPRGQGVPINTNSSP DDQIGYYRRATRRIRGGDGK MKDLSPRWYFYYLGTGPEAG LPYGANKDGIIWVATEGALN TPKDHIGTRNPANNAAIVLQ LPQGTTLPKGFYAEGSRGGS QASSRSSSRSRNSSRNSTPG SSRGTSPARMAGNGGDAALA LLLLDRLNQLESKMSGKGQ

Additional Info

Background Recombinant SARS-CoV-2 (2019-nCoV) Nucleocapsid Protein is produced by E. coli expression system. The target protein is expressed with sequence (Met1-Ala419) of SARS-COV-2 (2019-nCoV) Nucleocapsid (Accession #QHD43423.2) fused with an 6×His tag at the N-terminus.

Information sourced from Uniprot.org

Citations

Product Review

Well-cited Academic Publications
KO-Validated 700+ Lines
Technical Support Expert Scientific Team
1-Year Guarantee Antibodies & Proteins